|
MELA Sciences Reports Third Quarter 2014 Financial Results
GlobeNewswire (press release) The debt and preferred stock issuances are convertible into the Company’s common stock at a conversion price of $2.565 per share. Issued common stock purchase warrants at an effective exercise price of $2.45 per share, with warrants to purchase 4.8 … |
